Fatty acid composition of HDL phospholipids and coronary artery disease

Journal of Clinical Lipidology

Volumn 3, Issue 1, 2009, Pages 39-44

  Noori, Mohammad ^a   Darabi, Masoud ^a   Rahimipour, Ali ^a   Rahbani, Mohammad ^a   Abadi, Naser Aslan ^b   Darabi, Maryam ^c   Ghatrehsamani, Keyhan ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CAD; Fatty acids; HDL composition

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; LINOLEIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 59249083866     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2008.11.010     Document Type: Article

References (28)

1. Paganelli F., Maixent J.M., Duran M.J., et al. Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease. Int J Cardiol 78 (2001) 27-32
2. Block R.C., Harris W.S., Reid K.J., Sands S.A., and Spertus J.A. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 197 (2008) 821-828
3. Ghahremanpour F., Firoozrai M., Darabi M., Zavarei A., and Mohebbi A. Adipose tissue trans fatty acids and risk of coronary artery disease: a case control study. Ann Nutr Metab 52 (2008) 24-28
4. Bucher H.C., Hengstler P., Schindler C., and Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112 (2002) 298-304
5. Holub D.J., and Holub B.J. Omega-3 fatty acids from fish oils and cardiovascular disease. Mol Cell Biochem 263 (2004) 217-225
6. Hu F.B., Manson J.E., and Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 20 (2001) 5-19
7. Harris W.S., Miller M., Tighe A.P., Davidson M.H., and Schaefer E. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197 (2008) 12-24
8. Miettinen T.A., Naukkarinen V., Huttunen J.K., and Kumlin T. Fatty-acid composition of serum lipids predicts myocardial infarction. BMJ 285 (1982) 993-996
9. Salomaa V.V., Salminen I., Rasi V., et al. Association of the fatty acid composition of serum phospholipids with hemostatic factors. Arterioscler Thromb Vasc Biol 17 (1997) 809-813
10. Rye K., Duong M., Psaltis M.K., et al. Evidence that phospholipids play a key role in high density lipoprotein remodeling. Biochemistry 41 (2002) 12538-12545
11. Chen M.F., Wang T.D., Yeh H.T., Hsu H.C., and Lee Y.T. Gemfibrozil treatment potentiates oxidative resistance of high density lipoprotein in hypertriglyceridemic patients. Eur J Clin Invest 31 (2001) 707-713
12. Assmann G., Schriewer H., Schmitz G., and Hagele E.O. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem 29 (1983) 2026-2030
13. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
14. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957) 497-509
15. Brekke O.L., Espevik T., Bardal T., and Bjerve K.S. Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells. Lipids 27 (1992) 161-168
16. Lepage G., and Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27 (1986) 114-120
17. Oh K., Hu F.B., Manson J.E., Stampfer M.J., and Willett W.C. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol 161 (2005) 672-679
18. Shekelle R.B., Shryock A.M., Paul O., et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med 304 (1981) 65-70
19. Kark J.D., Kaufmann N.A., Binka F., Goldberger N., and Berry E.M. Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr 77 (2003) 796-802
20. Erkkila A.T., Matthan N.R., Herrington D.M., and Lichtenstein A.H. Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD. J Lipid Res 47 (2006) 2814-2819
21. De C.R., Liao J.K., and Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 71 (2000) 213S-223S
22. Zhao G., Etherton T.D., Martin K.R., et al. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 336 (2005) 909-917
23. Weldon S.M., Mullen A.C., Loscher C.E., Hurley L.A., and Roche H.M. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 18 (2007) 250-258
24. Ferrucci L., Cherubini A., Bandinelli S., et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91 (2006) 439-446
25. Baker P.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J Lipid Res 41 (2000) 1261-1267
26. Rise P., Eligini S., Ghezzi S., Colli S., and Galli C. Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukot Essent Fatty Acids 76 (2007) 363-369
27. Griffin B.A. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol 19 (2008) 57-62
28. Harris W.S., Poston W.C., and Haddock C.K. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193 (2007) 1-10